In conclusion, COVID-19 may upregulate the vWF/FBLN5 signaling pathway in the patients with severe/critical symptoms, thereby increasing the likelihood of extracorporeal coagulation during hemodialysis in CKD patients. The gene discussed is FBLN5; the disease is chronic kidney disease.